Emerging uses of circulating tumor DNA in advanced stage non-small cell lung cancer

Targeted therapies have dramatically changed the treatment paradigm for a select group of patients with non-small cell lung cancer (NSCLC) whose tumors harbor targetable genetic aberrations. Patients with such genetic changes enjoy excellent responses to tyrosine kinase inhibitors (TKIs), but resist...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Transl Med
Asıl Yazarlar: Marmarelis, Melina, Thompson, Jeffrey C., Aggarwal, Charu, Evans, Tracey L., Carpenter, Erica, Cohen, Roger B., Langer, Corey J., Bauml, Joshua
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AME Publishing Company 2017
Konular:
Review Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5635259/
https://ncbi.nlm.nih.gov/pubmed/29057240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.07.29
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller